skip to Main Content

AIM round-up: Helium One, Coral Products, Synairgen


Despite spending the bulk of Wednesday’s session in negative territory, the AIM index managed to scrape a positive finish, settling less than a point higher at 1074.48.

  • Helium One +51%
  • Coral Products +31%
  • Kazera Global -14%
  • N4 Pharma -14%
  • Synairgen -11%

Helium One Global [LON: HE1] floated to the top of the board today, adding 51%, following its debut on Friday. This is the product of a merger with Attis one and a refinancing so there appears to be some lag in terms of pricing but with no firm news, the stock could be subject to some volatility in the near term.

Coral Products [LON:CRU] also fared well today, adding 31% in the wake of well received full year results. Whilst sales fell, margins were maintained and despite the cautious tone of the outlook statement, shares still found room for support.

Kazera Global [LON:KZG] was the day’s biggest faller, off by 14%, although the stock put in a strong performance in the latter part of last week off the back of an update from its Namibian operations. Shares remain well above recent levels and this looks like little more than a degree of profit taking.

N4 Pharma [LON:N4P] was also one of the worst performers, off close on 14%, although again it appears to be a case of profit taking after strong gains at the end of last week. Its formulation work update on Dec 3rd seemed to drive a degree of interest, buat again this deserves some context – shares remain up well over 50% on the week.

Synairgen [LON:SNG] made in onto the list yesterday following the rally, but with no supporting news today, the stock again receives our notable mention having slipped 11%. It may be one of the biggest fallers but it’s also important to bear in mind that the applications for their technologies go well beyond COVID.

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

The Armchair Trader's 'How to' Guides

Read our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

Listen to our latest podcast episodes

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
CME Group
Back To Top